Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Allergy & Immunology
•
Urticaria/Angioedema
Is there a role for genetic testing after diagnosing HAE?
Related Questions
Would you still consider Omalizumab for CSU with Angioedema in a patient with Factor V Leiden Deficiency?
How often do you rely on using the C1 inhibitor functional assay versus the quantitative level alone to diagnose HAE?
Do you start omalizumab in childbearing patients with CSU?
How do you interpret high C1q binding assay with otherwise normal C1q, C3, C4, CH50 in a patient with recurrent urticaria with positive ANA at high titer 1:1280, negative dsDNA, RNP, SM, normal CBC, CMP, UA, and UPCR.
How do you approach performing a food challenge in a patient with CSU who is dependent on their H1 blockers?
What medications do you counsel patients to avoid if they develop ACEi angioedema?
What treatments do you consider for cholinergic urticaria refractory to high dose H1 blockers and omalizumab?
What is your preferred prophylactic agent in idiopathic angioedema?
Is there a role for phenotyping patients with CSU outside of a research setting by ordering IgG-anti-TPO, IgG-anti-FceRI , total IgE, total IgA etc.?
Can Xolair (omalizumab) be safely used in combination with biologics for patients with rheumatic disease?
